MMED is trading 4.8% up at $15.66 today. - The healthcare sector, including diabetes care companies, is seeing positive sentiment from Medicare's new "GLP-1 Bridge" program, expanding access to weight-loss medications for eligible U.S. seniors starting today, July 1, 2026. - MiniMed Group (MMED) also benefits from recent positive fiscal 2026 results and analyst support. - Shares are bucking the broader market trend, as major U.S. indices trade slightly lower today.